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Abstract— It is a one-sided hypothesis testing process for assessing
bioequivalence. Bootstrap and modified large-sample(MLS) methods
are considered to study individual bioequivalence(IBE), type I error
and power of hypothesis tests are simulated and compared with
FDA(2001). The results show that modified large-sample method is
equivalent to the method of FDA(2001) .
Keywords—individual bioequivalence; bootstrap; Bayesian boot-
strap; modified large-sample
I. INTRODUCTION
THE aim of bioequivalence(BE) studies is to assess theequivalence of two pharmaceutical drug of the same
active drug substance(Wijnand [1]). BE generally have three
types including average bioequivalence (ABE), population
bioequivalence (PBE) and individual bioequivalence(IBE).
ABE focuses only on the difference of average measure be-
tween test drug(T) and reference drug(R), the interest measure
may be area under curve and peak concentration. But ABE
ignores the variability of the measure for T and R. PBE
emphasizes total variability of the measure in population. IBE
takes into account the within-subject variability and subject-
by-formulation interaction for T and R. The mixed-effects
model usually be used to evaluate BE.
The original bootstrap method is used to study BE
(FDA [2]). FDA [3] proposed a parametric method to evalu-
ate BE. Shao et al. [4] improved the assessing procedure of
FDA [1]. Pigeot [5] continued to investigate IBE by bootstrap
percentile method. Wan et al. [6] investigated IBE by bootstrap
and Bayesian bootstrap methods, but they did not consider
the type I error for hypothesis testing. In this paper we
shall give the type I error and compare the modified large-
sample method with bootstrap methods. Efron [7] proposed a
new method named bootstrap which can simulate confidence
interval for interest parameter such as mean and variance.
Now there are many different styles about the bootstrap. The
asymptotic theory of bootstrap can be seen in the literatures
(e.g., Singh [8]; Bickel and Freedman [9]).
The hybrid bootstrap percentile method is to approximate
the distribution of θˆ − θ by θˆ∗ − θˆ. On the basis of bootstrap
percentile method, the approximated upper confidence bound
is 2θˆ − θˆ∗(Bα). Hall [10] pointed out the coverage error was
also O(n− 12 ). Rubin [11] proposed the Bayesian bootstrap
method to construct confidence interval.
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Ting et al. [12] extended the idea of modified large-
sample(MLS) method to obtain an upper confidence bound
for η = c1σ21 + · · · + cpσ2p in which ci(i = 1, 2, . . . , p) has
different sign. The 1-α upper confidence bound is
c1σˆ
2
1+ · · ·+cpσˆ2p+
√
c21σˆ
4
1(
n1
u1
− 1)2 + · · ·+ c2pσˆ4p(
np
up
− 1)2,
(1)
where
ui =
{
χ2α,ni , ci > 0,
χ2α,ni , ci < 0,
(2)
ni denotes the number of samples in each sequence and
σˆ21 , σˆ
2
2 , · · · , σˆ2p are independent. Lee et al. [13] considered the
case that σˆ21 , σˆ22 , · · · , σˆ2p are dependent and used the new
method to evaluate PBE.
The rest of this article is organized as follows. In Section 2,
we provide a description of the statistical model and criteria
for evaluating IBE in Appendix G of FDA’s Guidance [3]. In
Section 3, the power of different bootstrap methods and MLS
method for test procedures is simulated, and the type I error
of several tests is investigated. We present some conclusions
in Section 4.
II. STATISTICAL MODEL AND CRITERIA
To assess IBE s-sequence and four-period experiment usu-
ally be considered. FDA [3] recommended the mixed-effect
model
Yijkl = µk + γikl + δijk + εijkl (3)
where i = 1, 2, . . . , s indicates sequence, j = 1, 2, . . . , ni
indicates subject within sequence i, k=R,T denotes treatment,
l=1,2 denotes replicate on treatment k for subjects within
sequence i. Yijkl is the response of replicate l on treatment k
for subject j in sequence i, γikl represents the fixed effect of
replicate l on treatment k in sequence i, δijk is the random
subject effect for subject j in sequence i on treatment k, and
εijkl is the random error for subject j within sequence i on
replicate l of treatment k.
The linearized criteria are as follows in FDA [3]
(a) reference-scaled(σ2WR ≥ σ2W0):
η1 = (µT − µR)2 + σ2D + σ2WT − σ2WR − θI · σ2WR, (4)
(b) constant-scaled(σ2WR < σ2W0):
η2 = (µT − µR)2 + σ2D + σ2WT − σ2WR − θI · σ2W0, (5)
where µT and µR indicate population average responses of the
log-transformed measure for the T and R formulation, respec-
tively. σ2D = σ2BT + σ2BR − 2ρσBTσBR indicates subject-by-
formulation interaction variance component, σ2WT and σ2WR
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represent the within-subject variance of the T formulation and
R formulation, respectively. σ2W0 represents specified constant
within-subject variance and θI BE limit. Consider the testing
hypothesis
H0 : η ≥ 0 versus H1 : η < 0 (6)
where η = η1 if σ2WR ≥ σ2W0 and η = η2 if σ2WR < σ2W0.
Some statistics are defined as follows:
Iij = YijT · − YijR·, Tij = YijT1 − YijT2,
Rij = YijR1 − YijR2, i=1,2,...,s, j=1,2,...,ni,
YijT · =
1
2 (YijT1 + YijT2), YijR· =
1
2 (YijR1 + YijR2),
µˆk =
1
s
∑s
i=1 Yi·k·, k=R,T.
Yi·k· =
1
ni
∑ni
j=1
1
2
∑2
l=1 Yijkl , ∆ˆ = µˆT − µˆR,
MI = σˆ
2
I =
1
nI
∑s
i=1
∑ni
j=1(Iij − Ii·)2,
MT = σˆ
2
WT =
1
2nT
∑s
i=1
∑ni
j=1(Tij − Ti·)2,
MR = σˆ
2
WR =
1
2nR
∑s
i=1
∑ni
j=1(Rij −Ri·)2,
nI = nT = nR =
∑s
i=1 ni − s.
Ii· =
1
ni
∑ni
j=1 Iij , Ti· =
1
ni
∑ni
j=1 Tij ,
Ri· =
1
ni
∑ni
j=1 Rij .
Then the above linearized criteria are estimated by
(c) reference-scaled(MR ≥ σ2W0):
η˜1 = ∆ˆ
2 +MI + 0.5MT − (1.5 + θI)MR, (7)
(d) constant-scaled(MR < σ2W0):
η˜2 = ∆ˆ
2 +MI + 0.5MT − 1.5MR − θIσ2W0. (8)
Compute the 95% upper bound of the parameter η . If the
upper bound is negative or zero, we can draw a conclusion
that the IBE is equivalent for T and R. To calculate the upper
bound there are parametric methods such as FDA [3] and
nonparametric method(e.g., FDA [2]; Shao et al. [4]). On the
basis of the mixed-model(FDA[3]), we study IBE by using
bootstrap and Bayesian bootstrap methods.
Note that
σ2I = var(
YijT 1+YijT 2
2 −
YijR1+YijR2
2 ),
σ2WT = var(
YijT 1−YijT 2
2
√
2
), σ2WR = var(
YijR1−YijR2
2
√
2
),
and cov(YijT 1−YijT 2
2
√
2
,
YijR1−YijR2
2
√
2
) = 0,
cov(
YijT1 + YijT2
2
− YijR1 + YijR2
2
,
YijT1 − YijT2
2
√
2
) = 0,
cov(
YijT1 + YijT2
2
− YijR1 + YijR2
2
,
YijR1 − YijR2
2
√
2
) = 0,
since cov(T1, T2) = σ2BT , cov(R1, R2) = σ2BR,
cov(T1, R1) = cov(T1, R2) = cov(T2, R1) = cov(T2, R2) =
ρσBTσBR. Hence MI ,MT ,MR are independent.
III. SIMULATION RESULTS
Given s=2 and n1 = n2 = n, let
y1j = (Y1jT1, Y1jT2, Y1jR1, Y1jR2),
y2j = (Y2jT1, Y2jT2, Y2jR1, Y2jR2),
(j = 1, 2, . . . , n), the bootstrap sample (y∗11, y∗12, . . . , y∗1n)
and (y∗21, y∗22, . . . , y∗2n) are drawn from (y11, y12, . . . , y1n) and
(y21, y22, . . . , y2n) with replacement, respectively.
We choose appropriate criterion to calculate ηˆ∗1 or ηˆ∗2 , either
ηˆ∗1 or ηˆ
∗
2 denoted by ηˆ∗1.
The following methods (M1-M4) can be found in [6].
(M1) bootstrap percentile method(BP): For each bootstrap
sample, we calculate the bootstrap estimator M∗R of σ2WR to
compare with σ2W0 = 0.04 so as to choose the approximate
the criterion. Repeat the above step B times (choose B=500),
we can calculate the bootstrap estimator ηˆ∗b(b = 1, 2, . . . , B)
of η, let ηˆ∗(i) represent the i-th largest number of ηˆ∗b(b =
1, 2, . . . , B). The approximate 100(1 − α) confidence upper
bound is ηˆ∗(B− Bα) for η . IBE is equivalent to T and R if
ηˆ∗(B− Bα) ≤ 0 .
(M2) hybrid bootstrap percentile method(HBP): We analo-
gously compute the approximate 100(1−α) confidence upper
bound for η is 2ηˆ − ηˆ∗(Bα). IBE is equivalent to T and R if
2ηˆ − ηˆ∗(Bα) ≤ 0 .
(M3) Bayesian bootstrap percentile method(BBP): To es-
timate the interest parameters ∆, σ2I , σ2WT and σ2WR, we
generate s random vectors Vi=D(ni; 1, 1, ..., 1) (i=1,2,...,s).
Then the Bayesian bootstrap estimator of ∆ is
∆ˆ∗ =
1
s
s∑
i=1
ni∑
j=1
VijIij . (9)
The Bayesian bootstrap estimators of σ2I , σ2WT and σ2WR are
M∗I =
1
nI
s∑
i=1
ni
ni∑
j=1
Vij(Iij −
ni∑
j=1
VijIij)
2, (10)
M∗T =
1
2nT
s∑
i=1
ni
ni∑
j=1
Vij(Tij −
ni∑
j=1
VijTij)
2, (11)
and
M∗R =
1
2nR
s∑
i=1
ni
ni∑
j=1
Vij(Rij −
ni∑
j=1
VijRij)
2, (12)
respectively. Denoted Bayesian bootstrap estimator of η by
ηˆ∗bBB(b = 1, 2, . . . ,B). IBE is equivalent to T and R if
ηˆ∗BB(B− Bα) ≤ 0 .(M4) hybrid Bayesian bootstrap percentile method (HBBP):
The process for assessing IBE is similar to Bayesian bootstrap
percentile method. IBE can be claimed for T and R if 2ηˆ −
ηˆ∗BB(Bα) ≤ 0 .(M5) by the work of Section 2 we use formulas (1) and (2)
to calculate the upper confidence bound for the parameter η.
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The following parameter setting to enable H0 hold is
considered (ps represents parameter setting).
ps µT − µR σ2WT σ2WR σ2BT σ2BR ρ η
1 0.30 0.06 0.01 0.03 0.01 0.9 0.0490
2 0.30 0.03 0.01 0.06 0.03 0.9 0.0238
3 0.40 0.10 0.03 0.09 0.01 0.9 0.1762
4 0.10 0.02 0.01 0.03 0.02 0.9 0.0262
The above six methods are used to evaluate IBE for the
dataset in [1]. Let α = 0.05, the 1 − α upper confidence
bound are -0.0305, -0.0425, -0.0506, -0.0505, -0.0471 and -
0.0316, respectively, the smallest number is -0.0505 which is
associated with Bayesian bootstrap percentile method.
TABLE I
TYPE I ERROR SIMULATION
ps method β (n=12) β (n=24) β (n=36) β (n=48)
1 FDA’s 0 0 0 0
BP 0.05 0.01 0 0
HBP 0.01 0 0 0
BBP 0 0 0 0
HBBP 0 0 0 0
MLS 0 0 0 0
2 FDA’s 0.01 0.03 0.04 0.04
BP 0.10 0.20 0.16 0.18
HBP 0.15 0.13 0.13 0.15
BBP 0.09 0.08 0.07 0.09
HBBP 0.12 0.09 0.09 0.07
MLS 0.01 0.03 0.04 0.04
3 FDA’s 0 0 0 0
BP 0 0 0 0
HBP 0 0 0 0
BBP 0 0 0 0
HBBP 0 0 0 0
MLS 0 0 0 0
4 FDA’s 0 0.01 0 0
BP 0.04 0.04 0.03 0.02
HBP 0.07 0.05 0 0.03
BBP 0.05 0.02 0.01 0
HBBP 0.07 0.01 0.01 0
MLS 0 0.01 0 0
The following parameter setting is considered:
ps µT − µR σ2WT σ2WR σ2BT σ2BR ρ η
1 0.10 0.06 0.05 0.03 0.02 0.9 -0.0988
2 0.10 0.03 0.01 0.03 0.02 0.9 -0.0639
3 0.20 0.03 0.03 0.03 0.02 0.9 -0.0539
4 0.20 0.02 0.01 0.03 0.02 0.9 -0.0439
All these above 4 parameters setting satisfy η < 0. For
each parameter setting we generate 100 groups random nubers
under the model in FDA [3] and B=500 bootstrap samples for
each group. Denote β the number that the upper confidence
bound of η is less than or equal to 0, then β/100 means the
power simulated for the test procedure. We evaluate IBE by
parametric method (FDA [3]), BP mehtod, HBP method, BBP
method, HBBP method and MLS mtehod (see, Ting et al. [12];
Lee et al. [13]) at significance level α = 0.05.
IV. CONCLUSION
As shown in the above tables, we see that modified large-
sample method achieves the same type I error and power of
FDA [3].
TABLE II
POWER SIMULATION
ps method β (n=12) β (n=24) β (n=36) β (n=48)
1 FDA’s 0.75 0.92 1 1
BP 0.73 0.92 0.98 1
HBP 0.59 0.83 0.90 0.98
BBP 0.96 1 1 1
HBBP 0.81 0.90 0.99 0.99
MLS 0.81 0.90 0.99 0.99
2 FDA’s 0.95 1 1 1
BP 0.97 1 1 1
HBP 0.85 0.94 0.98 1
BBP 1 1 1 1
HBBP 0.98 1 1 1
MLS 0.81 0.90 0.99 0.99
3 FDA’s 0.67 0.90 0.97 0.99
BP 0.81 0.88 0.99 1
HBP 0.65 0.78 0.75 0.86
BBP 1 1 1 1
HBBP 0.53 0.58 0.68 0.76
MLS 0.81 0.90 0.99 0.99
4 FDA’s 0.87 0.99 1 1
BP 0.91 0.97 1 1
HBP 0.71 0.88 0.95 0.98
BBP 1 1 1 1
HBBP 0.50 0.51 0.79 0.81
MLS 0.81 0.90 0.99 0.99
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